Understanding the interfacial behavior in isopycnic Lennard-Jones mixtures by computer simulations

文献信息

发布日期 2015-11-26
DOI 10.1039/C5CP06562C
影响因子 3.676
作者

José Matías Garrido, Manuel M. Piñeiro, Andrés Mejía, Felipe J. Blas


查看原文

摘要

The physical characterization of the singular interfacial behavior of heterogeneous fluid systems is a very important step in preliminary stages of the design process, and also in the subsequent procedures for the determination of the optimal operating conditions. Molar isopycnicity or molar density inversion is a special case of phase equilibrium behavior that directly affects the relative position of phases in heterogeneous mixtures, without being affected by gravitational fields. This work is dedicated to characterize the impact of molar density inversion on the interfacial properties of Lennard-Jones binary mixtures. The results and specific trends of the molar density inversion phenomena on the peculiar calculated composition profiles across the interface and interfacial tensions are explored by using canonical molecular dynamics simulations of the Lennard-Jones binary mixtures. Our results show that the density inversion causes drastic changes in the density profiles of the mixtures. In particular, symmetrical and equal-sized Lennard-Jones mixtures always exhibit desorption along the interfacial zone, i.e. the interfacial concentration profiles show a relative minimum at the interface of the total density profiles that increases when the dispersive energy parameter (εij) between unlike species decreases. However, as the asymmetry of the Lennard-Jones mixtures increases (σi ≠ σj), the concentration profiles display a relative maximum at the interface, which implies the adsorption of the total density profiles along the interfacial zone.

相关文献

Target 2035 – update on the quest for a probe for every protein

Susanne Müller, Suzanne Ackloo, Arij Al Chawaf, Hartmut Beck, Shaunna Beedie, Ulrich A. K. Betz, Gustavo Arruda Bezerra, Paul E. Brennan, David Brown, Peter J. Brown, Alex N. Bullock, Adrian J. Carter, Apirat Chaikuad, Mathilde Chaineau, Alessio Ciulli, Ian Collins, Jan Dreher, Kristina Edfeldt, Aled M. Edwards, Ursula Egner, Stephen M. Fuchs, Matthew D. Hall, Ingo V. Hartung, Alexander Hillisch, Stephen H. Hitchcock, Evert Homan, Natarajan Kannan, James R. Kiefer, Stefan Knapp, Milka Kostic, Stefan Kubicek, Andrew R. Leach, Sven Lindemann, Hisanori Matsui, Jordan L. Meier, Maurice Michel, Maxwell R. Morgan, Anke Mueller-Fahrnow, Dafydd R. Owen, Benjamin G. Perry, Saul H. Rosenberg, Kumar Singh Saikatendu, Cora Scholten, Sujata Sharma, Anton Simeonov, Michael Sundström, Matthew H. Todd, Claudia Tredup, Timothy M. Willson, Georg E. Winter

2021-12-03 Opinion

DOI: 10.1039/D1MD00228G

Benzimidazole-1,2,3-triazole hybrid molecules: synthesis and study of their interaction with G-quadruplex DNA

Ushasri Chilakamarthi, Namita S. Mahadik, Bhamidipati Keerti, Santosh N. Mokale, Narayana Nagesh

2021-02-22 Research Article

DOI: 10.1039/D0MD00414F

Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases

Feilong Zhou, Jin-Ming Yang

2021-01-22 Review Article

DOI: 10.1039/D0MD00361A

Discovery, synthesis and biological characterization of a series of N-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators

Swagat Sharma, Lauren Lesiak, Christopher D. Aretz, Yu Du, Sushil Kumar, Nagsen Gautam, Yazen Alnouti, Nikilesh V. Dhuria, Yashpal S. Chhonker, C. David Weaver, Corey R. Hopkins

2021-06-21 Research Article

DOI: 10.1039/D1MD00129A

Front cover

2021-07-21 Cover

DOI: 10.1039/D1MD90025K

Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity

Anjali Patel, Subhasis Dey, Kamal Shokeen, Tomasz M. Karpiński, Senthilkumar Sivaprakasam, Sachin Kumar

2021-05-24 Research Article

DOI: 10.1039/D1MD00091H

Identification of P218 as a potent inhibitor of Mycobacterium ulcerans DHFR

Rachael Zigweid, Bart L. Staker

2020-10-22 Research Article

DOI: 10.1039/D0MD00303D

Profiling MAP kinase cysteines for targeted covalent inhibitor design

Ruibin Liu, Neha Verma, Jack A. Henderson, Shaoqi Zhan, Jana Shen

2021-11-03 Research Article

DOI: 10.1039/D1MD00277E

Anti-amyloidogenic indolizino[3,2-c]quinolines as imaging probes differentiating dense-core, diffuse, and coronal plaques of amyloid-β

Kyeonghwan Kim, Jeong Hwa Lee, Sunmi Kim, Songmin Lee, Donghee Lee, Hye Yun Kim, Ikyon Kim, YoungSoo Kim

2021-10-11 Research Article

DOI: 10.1039/D1MD00030F

A review of the latest research on Mpro targeting SARS-COV inhibitors

Huihui Yang

2021-04-14 Review Article

DOI: 10.1039/D1MD00066G

您可能还喜欢

化合物问答

什么是2-氨基戊烷(CAS号:63493-28-7)?

2-氨基戊烷,又名pentan-2-amine,是一种有机化合物,分子式为C5H11NH2。它是一种无色透明液体,有氨味。该化合物在工业和研究中有一定的应用。

63493-28-7pentan-2-amine
化合物问答

反式-4-[4-[[[5-[(3,4-二氟苯基)氨基]-1,3,4-恶二唑-2-基]羰基]氨基]苯基]环己烷乙酸(CAS号:892489-52-0)的物理化学性质是什么?

该化合物为白色固体,分子量为552.31 g/mol。它在水中溶解度较低,在有机溶剂如乙腈、乙酸乙酯中有较好的溶解性。该化合物具有较高的化学稳定性,对酸和碱具有...

892489-52-0Trans-4-[4-[[[5-[(3,...
化合物问答

如何处理含有Pyrotinib dimaleate(CAS号:1397922-61-0)的废料?

处理含有Pyrotinib dimaleate 的废料时,应遵循当地的法规要求。首先,收集废料并进行分类,确保没有与其他化学品混合。然后,采取适当的物理和化学处...

1397922-61-0(2E)-N-(4-{[3-Chloro...
化合物问答

在合成中是否有4-(5-5-乙基-1,2,4-噁二唑-3-基)苯甲酸乙酯(CAS号:1166756-79-1)的替代品?

在合成过程中,可以考虑使用其他结构类似的化合物作为替代品,例如苯甲酸酯类化合物,如2-乙基-5-甲基噁二唑基苯甲酸乙酯等。这些替代品可能具有相似的化学性质,但在...

1166756-79-1Ethyl 4-(5-ethyl-1,2...
化合物问答

如何处理含有1-((叔丁氧基羰基)氨基)环丁烷甲酸甲酯(CAS号:880166-10-9)的废料?

处理含有该化合物的废液时,应先确保其完全反应并转化为无害物质。对于未反应的化合物,建议采用中和处理后进行蒸馏回收,剩余物可使用化学氧化法或焚烧法进行无害化处理。...

880166-10-9Methyl 1-({[(2-methy...
化合物问答

2-({[3,5-二(三氟甲基)苯基]磺酰基}氨基)-4-(甲基硫代)丁酸甲酯(CAS号:175202-21-8)的市场或研究趋势如何?

目前该化合物主要应用于药物合成领域,尤其在开发新型抗癌药物方面具有潜在应用。随着制药行业的持续发展,对于高效、低毒的合成中间体需求增加,预计该化合物的研究和应用...

175202-21-8Methyl N-{[3,5-bis(t...
化合物问答

N,N-乙烯双(碘乙酰胺)(CAS号:7250-43-3)的物理化学性质是什么?

N,N-乙烯双(碘乙酰胺)是一种白色或类白色固体,易溶于乙醇、丙酮等有机溶剂,但在水中溶解度较低。该化合物具有较高的反应活性,可以与其他含有活性氢的化合物发生酰...

7250-43-3N,N'-1,2-Ethanediylb...
化合物问答

7-Fluoro-1H-spiro[furo[3,4-c]pyridine-3,4'-piperidine](CAS号:1283090-73-2)通常如何合成?

该化合物可以通过环合反应合成,首先合成吡啶和哌啶的衍生物,然后在合适的条件下进行环合反应得到目标化合物。常用的催化剂包括某些金属盐类,产率一般在70%-90%之...

1283090-73-27-Fluoro-1H-spiro[fu...
化合物问答

处理3-乙酰滇乌碱(CAS号:80787-51-5)时应注意哪些实验室安全事项?

在处理3-乙酰滇乌碱时,应穿戴适当的个人防护装备(PPE),如实验服、手套(丁腈手套或PVC手套)、护目镜和口罩。实验应在通风橱中进行,以减少吸入或皮肤接触的风...

80787-51-54-Methylaconitane-1,...
化合物问答

如何储存2-溴-5-硝基-4-羧酸(CAS号:1053655-82-5)?

2-溴-5-硝基-4-羧酸应存放在阴凉、干燥、通风良好的地方,远离火源和热源。避免与还原剂、碱性物质接触。储存容器应密封,防止吸湿。

1053655-82-52-Bromo-5-nitropyrid...

来源期刊

Physical Chemistry Chemical Physics

Physical Chemistry Chemical Physics
CiteScore: 5.5
自引率: 10.3%
年发文量: 3036

Physical Chemistry Chemical Physics (PCCP) is an international journal co-owned by 19 physical chemistry and physics societies from around the world. This journal publishes original, cutting-edge research in physical chemistry, chemical physics and biophysical chemistry. To be suitable for publication in PCCP, articles must include significant innovation and/or insight into physical chemistry; this is the most important criterion that reviewers and Editors will judge against when evaluating submissions. The journal has a broad scope and welcomes contributions spanning experiment, theory, computation and data science. Topical coverage includes spectroscopy, dynamics, kinetics, statistical mechanics, thermodynamics, electrochemistry, catalysis, surface science, quantum mechanics, quantum computing and machine learning. Interdisciplinary research areas such as polymers and soft matter, materials, nanoscience, energy, surfaces/interfaces, and biophysical chemistry are welcomed if they demonstrate significant innovation and/or insight into physical chemistry. Joined experimental/theoretical studies are particularly appreciated when complementary and based on up-to-date approaches.

推荐供应商

免责声明
本页面提供的学术期刊信息仅供参考和研究使用。我们与任何期刊出版商均无关联,也不处理投稿事宜。如有投稿相关咨询,请直接联系相关期刊出版商。
如发现页面信息有误,请发送邮件至 support@chemtradehub.com 联系我们。我们将及时核实并处理您的问题。